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Abstract: Although neuronal density analysis on human brain slices is available from stere-
ological studies, data on the spatial distribution of neurons in 3D are still missing. Since the
neuronal organization is very inhomogeneous in the cerebral cortex, it is critical to map all
neurons in a given volume rather than relying on sparse sampling methods. To achieve this goal,
we implement a new tissue transformation protocol to clear and label human brain tissues and we
exploit the high-resolution optical sectioning of two-photon fluorescence microscopy to perform
3D mesoscopic reconstruction. We perform neuronal mapping of 100mm3 human brain samples
and evaluate the volume and density distribution of neurons from various areas of the cortex
originating from different subjects (young, adult, and elderly, both healthy and pathological).
The quantitative evaluation of the density in combination with the mean volume of the thousands
of neurons identified within the specimens, allow us to determine the layer-specific organization
of the cerebral architecture.
© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
1. Introduction
The three-dimensional reconstruction of large volumes of human brain tissue at cellular resolution
remains one of the biggest technical challenges of neuroscience. Nowadays, structural analyses
are obtained using traditional processes based on 2D evaluation of thin slices, but they still
suffer from significant drawbacks. Such limitations are inherent to the bidimensional nature of
the classical slide-based preparations and include: low sensitivity for sparse features, difficult
assessment of dimensions, alteration of morphology, visual artifacts (different orientation or
distribution), and sampling bias. To overcome the image depth limit and obtain high-resolution
reconstructions of whole mouse brain samples, several optical imaging combined with histological
techniques have been developed. Micro-optical sectioning tomography (MOST) [1–4], serial
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two-photon tomography (STP) [5], and block-face serial microscopy (FAST) [6], which exploit a
combined system of slicing and imaging, are examples of these approaches. In particular, the
Mouselight platform based on STP [7], and FAST use a vibratome for the slicing process, allowing
whole-brain imaging at a subcellular resolution. Despite the substantial advantages prompted
by automatic histology instrumentation and serial sectioning [8], lack of three-dimensionality
affects the quality of the produced data and reliability of the analysis.
Recent advances in tissue imaging — in terms of optical clearing, fluorescent staining, and
microscopy techniques — have paved the way to high-resolution 3D reconstruction of the brain
[9]. The combination of clearing methodologies and cutting-edge microscopies techniques as
light sheet microscopy enables the reconstruction of large volumes of tissue and even entire
organs [10–12]. Indeed, tissue clearing makes antigens and light penetrate deep inside the sample,
enabling fluorescence imaging through high-resolution optical techniques. Multiple methods have
been developed to achieve sound clearing and homogeneous staining, but only a few of them have
been applied to human tissue. Such samples, in particular archived materials, present specific
challenges in comparison to animal models: variability of post-mortem fixation conditions,
presence of blood inside the vessels, autofluorescence signals coming from lipofuscin-type
pigments, and, finally, the need of exogenous labeling [13]. Alteration of antigens, due to
fixation and/or long storage, prevent good immunostaining recognition. Normally, diffusion
limits the homogeneous penetration of the dye inside the tissue; voluminous macromolecules,
like antibodies, can penetrate only a few dozens of microns inside the sample. Among the various
techniques that favor diffusion and increase tissue transparency, tissue transformation techniques
such as the CLARITY method [14] and its adaptations have had considerable success. However,
they also have limitations. Some were developed for application only to specific samples: e.g.
pediatric tissue or controlled post mortem fixation conditions [15,16]. Others demonstrated
compatibility with few antibodies and/or can achieve a staining depth of only a few tens of microns
and/or are characterized by very long clearing time [17–22]. Indeed, prolonged formalin-fixed
materials are really difficult to clear with only SDS treatment. Different authors [18,21] point out
the necessity of performing a prolongation of the delipidation step up to several months in these
cases. Recently, ELAST was introduced [23], a technology that transforms tissues into elastic
hydrogel allowing the homogeneous staining of 1 cm-thick sections with various antibodies;
however, the preparation of the sample requires sophisticated custom-made equipment and long
processing time (20 days). Organic-based techniques were adapted to clear and label human brain
tissue, but also in this case they need specific sample preparations: fresh-frozen samples [24],
fetal brains [25], or in-situ controlled perfusion fixation [26,27]. In conclusion, up to now, we have
no flexible strategy for fast clearing of human brain specimens from different ages, formalin-fixed
for a long time, and compatible with different antibodies labelling. An additional consideration
that needs to be addressed is that the advances in tissue clearing need large-scale data analysis
and management. Indeed, high-throughput computational approaches are required to scale-up
the processing of the significant amount of data produced by 3D anatomical reconstructions
obtained by the combination of clearing techniques with high-resolution optical methods.
Considering the difficulties of human tissue labeling that decrease the quality of the produced
images, cell recognition in thick samples is very arduous with conventional microscopy. Here
we propose a new clearing method that in combination with an advanced optical microscopy
technique enables the reconstruction of mesoscopic volumes of the human brain at sub-micron
resolution and the study of the anatomical organization of neurons in 3D. First, we implement a
novel flexible methodology, the SWITCH/TDE protocol, to perform reliable clearing and labeling
of human cortical tissues. Following this clearing protocol, we exploit the high-resolution optical
sectioning of Two-Photon Fluorescence Microscopy to perform 3D mesoscopic imaging of human
brain samples. To analyze the large amount of generated data, we apply different software tools
to process the images in an automated fashion and extract reliable and quantitative information.
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A custom-made software called ZetaStitcher is used to stitch together the 3D tiles acquired with
the TPFM microscope. Then a 2.5D Machine Learning method based on a Convolutional Neural
Network is used to automatically segment the neurons in 3D to extract quantitative data (both
cell counting and cell volume reconstruction). The volumetric assessment, together with cell
counting, obtained with this approach allows us to extract morphological information such as
cell density, cell localization, cell average volume, and cell volumetric density, and discriminate
the layer organization of the cerebral cortex. We demonstrate the applicability of the approach by
reconstructing and analysing four different areas of the human cortex originating from different
subjects (young, adult, and elderly, both healthy and pathological).
2. Methods
2.1. Human brain specimen collection
The study was approved by the Pediatric Ethic Committees of the Tuscany Region (under the
project RF-2013-02355240 funded by the Italian Ministry of Health and the Tuscany Region).
Healthy tissue samples were obtained from the body donation program (Association des dons du
corps) of Université de Tours and from the Body Donation Program “Donation to Science” of the
University of Padova. Prior to death, participants gave their written consent for using their entire
body – including the brain – for any educational or research purpose in which anatomy laboratory
is involved. The authorization documents (under the form of handwritten testaments) are kept in
the files of the Body Donation Program. Pediatric human brain samples were removed during
surgical procedures for the treatment of drug-resistant epilepsy in children with malformations of
cortical development (MCD). Samples were obtained after informed consent, according to the
guidelines of the Pediatric Research Ethics Committee of the Tuscany Region. Upon collection,
samples were placed in neutral buffered formalin (pH 7.2–7.4) (Diapath, Martinengo, Italy) and
stored at room temperature until the transformation and clearing process. The four specimens
analyzed in the study were formalin fixated respectively for 6-months, 1-year, 4-years and 5-years.
The specimen shown in Fig. 1 was fixated for 7-years (the staining procedures with the antibodies
of Fig. 1 were performed on cut pieces of this sample).
2.2. SWITCH/TDE clearing and labelling protocol
Blocks of fixed samples were washed with a Phosphate Buffered Saline (PBS) solution at 4◦C
with gentle shaking for one month to remove formalin from the tissue. Blocks were embedded in
a low melting agarose (4 % in 0.01M PBS) and cut into (450 ± 50) µm coronal sections with a
vibratome (Vibratome 1000 Plus, Intracel LTD, UK). After the cutting, the agarose surrounding
each slice was removed. The permeabilization and staining protocols were modified from that
of Murray et al. 2015 [19], as described below. Samples were first incubated in the ice-cold
SWITCH-OFF solution (4 % GA in PBS 1X and KHP 0.1M, titrated with HCl to pH = 3) for 1
day at 4◦C with gentle shaking, then incubated for 1 day in the SWITCH-ON solution (0.5 %
GA in PBS 1X, pH = 7.6) for 1 day at 4◦C with gentle shaking. After two washing steps in the
PBST solution (PBS with 1 % Triton X-100, pH = 7.6) for 4 hours at room temperature (RT), the
samples were inactivated with a solution of 4 % w/v acetamide and 4 % w/v glycine with a pH
= 9 (overnight incubation at 37◦C). Two washing steps in PBST solution for 4 hours at room
temperature (RT) were performed before the incubation in the Clearing Solution (200mM SDS,
20mM Na2SO3, 20mM H3BO3, pH = 9) at 70◦C for lipids removal. Incubation time in clearing
solution was adapted depending on tissue characteristics: samples from pediatric patients were
kept overnight (6-8 hours), while samples from adult and elderly subjects up to one day, until
complete transparency was achieved. Two washing steps in the PBST solution for 8 hours at
room temperature (RT) were performed to prepare the sample for the labeling process. Primary
antibodies were incubated in the PBST solution for one day at 4◦C. After two washing steps
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Fig. 1. (a) Schematic illustration of the SWITCH/TDE clearing method. (b) 1 mm-thick
slice of an adult human brain sample before and after the treatment. (c) Images of SYTOX
Green labeled tissue at different depths. Scale bar = 100 µm. (d) Images of NeuN immunos-
tained tissue at different depths. Scale bar = 50 µm. Acquisition obtained with TPFM.
(e) Representative images of cleared tissues immunostained with various antibodies and
DAPI (4′, 6-Diamidino-2-Phenylindole, Dihydrochloride). Scale bar = 50 µm. Acronym
list: Neuron-specific Nuclear protein (NeuN, all neurons), Microtubule-Associated Protein
2 (MAP2; pyramidal cells), Nonphosphorylated neurofilament protein (SMI32; pyramidal
cells), Glutamic Acid Decarboxylase (GAD67; all GABAergic interneurons), Parvalbumin
(PV; GABAergic interneurons subtype), Calbindin (CB; GABAergic interneurons sub-
type), Vasointestinal peptide (VIP; GABAergic interneurons subtype), Somatostatin (SST;
GABAergic interneuron subtype), Neuropeptide Y (NPY; GABAergic interneuron subtype),
Neurofilament (NF), Ionized calcium Binding Adaptor molecule 1 (Iba1; glial cells), Glial
Fibrillary Acidic Protein (GFAP; glial cells), Glutamine synthetase (GluS), Vimentin (Vim;
Microvasculature), Collagen IV (Coll IV; microvasculature).
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in the PBST solution for 8 hours at RT, secondary antibodies were incubated in PBST for one
day at RT. Table 1 reports the list of antibodies and dilutions used. After two washing steps of 8
hours with PBST at RT, samples were fixed with a 4 % solution of paraformaldehyde (PFA) for
10min at 4◦C to avoid antibody detachment. Samples were then washed three times with PBS for
10min at RT to remove the excess of PFA. Optical clearing consists in incubation in solutions
of increasing concentrations of 20 %, 40 % and 68 % (vol/vol) of 2, 2′-thiodiethanol in 0.01M
PBS (TDE/PBS), each for 1 day at room temperature (RT) with gentle shaking. For nuclear
staining, DAPI or SYTOX Green were diluted in the last incubation of the sample in the 68 %
(vol/vol) TDE/PBS solution. For 1 mm thick samples, the incubation was performed for two
days. Finally, samples were mounted in a custom made chamber with UV silica cover slip (UQG
Optics, CFS-5215) that flattens the sample while keeping it completely covered by the TDE/PBS
solution allowing a perfect RI matching which is essential for imaging. Sample pictures before
and after the clearing process were acquired using a digital camera (Sony DSC-WX500), samples
were kept soaked either in PBS or TDE.
Table 1. Table summarizing the dyes tested in this study. The P/M column denotes polyclonal vs
monoclonal antibodies. The same abbreviations used in Fig. 1 are used. AF is a shorthand for Alexa
Fluor.
Molecule Company Cat. n. Host P/M Dilution
NeuN Merck ABN91 Chicken P 1:50
GAD67 Santa Cruz sc-28376 Mouse M 1:200
GAD65/67 St John’s Lab STJ93195 Rabbit P 1:200
PV Abcam ab11427 Rabbit P 1:200
PV Abcam ab32895 Goat P 1:200
CB Abcam ab207528 Rabbit M 1:200
VIP Abcam ab214244 Rabbit M 1:200
SST Abcam ab30788 Rat M 1:200
NPY Abcam ab6173 Sheep P 1:200
NPY Abcam ab112473 Mouse M 1:200
SMI-32 Merck NE1023 Mouse M 1:200
Neurofilament Abcam ab4680 Chicken P 1:200
GluS Merck MAB302 Mouse M 1:200
MAP2 Abcam ab5392 Chicken P 1:200
GFAP Abcam ab194324 Rabbit M 1:200
Iba1 Abcam ab195031 Rabbit M 1:200
Coll IV Abcam ab6586 Rabbit P 1:200
Vim Abcam ab8069 Mouse M 1:200
Anti-Rat IgG, AF 568 Abcam ab175475 Donkey P 1:200
Anti-Rabbit IgG, AF 568 Abcam ab175470 Donkey P 1:200
Anti-Chicken IgY, AF 568 Abcam ab175711 Goat P 1:200
Anti-Mouse IgG, AF 568 Abcam ab175700 Donkey P 1:200
Anti-Sheep IgG, AF 568 Abcam ab175712 Donkey P 1:200
Anti-Rabbit IgG, AF 488 Abcam ab150077 Goat P 1:200
Anti-Chicken IgY, AF 488 Abcam ab150169 Goat P 1:200
DAPI Thermo Fisher Scientific D1306 1:1000
SYTOX Green Thermo Fisher Scientific S7020 1:1000
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2.3. Two-photon fluorescence microscopy
A custom-made Two-Photon Fluorescence Microscope (TPFM) was built in order to enable
mesoscopic reconstruction of cleared samples. A mode-locked Ti:Sapphire laser (Chameleon,
120 fs pulse width, 80 MHz repetition rate, Coherent, CA) operating at 800 nm was coupled into
a custom-made scanning system based on a pair of galvanometric mirrors (LSKGG4/M, Thorlabs,
USA). The laser was focused onto the specimen by a refractive index tunable 25× objective lens
(LD LCI Plan-Apochromat 25×/0.8 Imm Corr DIC M27, Zeiss, Germany). The system was
equipped with a closed-loop XY stage (U-780 PILine XY Stage System, 135×85 mm travel range,
Physik Instrumente, Germany) for radial displacement of the sample and with a closed-loop
piezoelectric stage (ND72Z2LAQ PIFOC objective scanning system, 2 mm travel range, Physik
Instrumente, Germany) for the displacement of the objective along the z-axis. The fluorescence
signal was collected by two independent GaAsP photomultiplier modules (H7422, Hamamatsu
Photonics, NJ). Emission filters of (440 ± 40) nm, (530 ± 55) nm and (618 ± 25) nm were used
to detect the signal, respectively, for DAPI, Sytox Green/Alexa 488, and Alexa Fluor 568. The
instrument was controlled by a custom software, written in LabView (National Instruments, TX)
able to acquire a whole sample by performing z-stack imaging (depth = (500 ± 100) µm) of
adjacent regions with an overlap of 40 µm and a voxel size of 0.88× 0.88× 2 µm. The acquisition
was performed using a FOV of 450 µm resulting in 512x512 px images that were saved as TIFF
files. The microscope is characterized by a dwell time of 5 µs resulting in 1.31s per image, and
5.46 minutes per stack of 500 µm depth. Therefore the acquisition of the four samples took from
11 hours to 30 hours of continuous imaging.
2.4. Volumetric image stitching
To obtain a single file view of the sample imaged with the TPFM, the acquired stacks were fused
together using the ZetaStitcher tool [28]. This software can take advantage of the overlap between
neighboring stacks to correct the mechanical error of the imaging platform. Indeed, mesoscopic
reconstruction with TPFM can take several days, and temperature changes and mounting medium
evaporation can lead to some micron-scale distortion. The software is based on two steps: an
alignment process followed by image fusion. As a first step, a 2D cross-correlation map is
evaluated at several depths for every pair of adjacent 3D stacks, moving each stack relative to
its neighbor. The final position of all stacks is determined by applying a global optimization
algorithm to the displacements of the individual pairs. Finally, the stacks are fused into a 3D
reconstruction of the whole sample stored in a single TIFF file. The raw datasets of the four
samples under investigation in this paper are made available on the EBRAINS platform provided
by the Human Brain Project [29].
2.5. Automatic cell counting and segmentation
We used a 2D Convolutional Neural Network for pixel-based classification expanding on the
design employed in a previous work [30]. In this network architecture, 32 × 32 × 2 sized patches
(i.e. considering red and green channels) are extracted from the stitched volume, and fed to the
CNN model after a preprocessing step consisting of a single 5 × 5 gaussian kernel filtering stage
with σ = 3. This operation replicates the intrinsic blurring caused by resampling during data
augmentation in the training phase of the CNN. The neural network architecture consists of three
convolutional layers, the first two of which are followed by 2 × 2 max-pooling downsampling,
and three fully connected layers, the last of which makes use of a two-class softmax activation
function. A block diagram of the overall network structure as well as the trainable parameters
(205 024 in total) and optimizer hyper-parameters are described in the supplementary information.
The so-defined CNN model classifies the central pixel of each input patch by exploiting the visual
pattern of the local neighbourhood (i.e. the coloured 32 × 32 texture) to which the pixel belongs.
The model can be used for efficient inference on input data larger than the 32 × 32 patches by
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exploiting formal equivalence, named fully convolutional, between fully connected layers and
1 × 1 convolutions [31]. This allows us to efficiently produce heatmaps (i.e. probability maps)
of entire stack frames. These two-dimensional maps are reassembled back into a 3D stack to
obtain an estimate of the three-dimensional probability distribution of neuronal soma presence.
In particular, the obtained heatmaps are processed with two different filtering modalities in order
to optimize either cell counting or volumetric evaluation.
For cell counting, a 2D morphological erosion with 3 × 3 kernel is applied independently to
each 2D heatmap before the 3D reconstruction in order to optimize the separation of touching
neurons. For volume evaluation, the heatmap stack undergoes a post-processing step of false
positive reduction with the application of a 5 × 5 median filter and a gray-scale morphological
opening with a 3 × 3 structuring element. We consider the isosurfaces of this field corresponding
to a 0.55 statistical threshold to be representative of the physical boundaries of neuron soma;
to calculate them we use a custom variant of the Marching Cubes algorithm [32] followed by
additional topological fixes on the identified objects to ensure that every soma is represented by a
2-manifold watertight mesh. This approach allows us to retrieve a three-dimensional vectorial
reconstruction of the segmented objects in the entire z-stack, although limited by a grouping effect
Table 2. Number, mean volume and density of the neurons in the six layers and in the total volume
of the cortex for each four specimen.
Layer N. Neurons Tissue volume Density Mean Volume Filling
(mm−3) (103 mm−3) (µm3) fraction
Specimen 1
1 47329 2.880 17 2603 1.38 %
2 11580 0.486 33 2916 3.87 %
3 40684 1.758 27 4441 5.02 %
4 47433 1.814 31 3549 4.90 %
5 23290 1.300 24 4358 4.68 %
6 13843 0.769 22 2263 1.99 %
tot. 184159 9.007 24 3569 21.8 %
Specimen 2
1 178432 11.533 16 2550 1.5 %
2 193783 11.724 17 2567 1.8 %
3 219289 12.789 18 2922 2.3 %
4 97771 2.413 51 2730 6.5 %
5 78402 2.199 43 3324 6.4 %
6 41167 1.054 47 1989 3.8 %
tot. 808844 41.712 20 2740 22.4 %
Specimen 3
1 34997 1.646 21 2105 1.8 %
2 36697 1.432 26 3412 5.3 %
3 66012 3.464 19 4627 5.7 %
4 46979 1.804 26 3524 5.8 %
5 55617 2.387 23 4584 6.4 %
6 16912 5.656 3 3410 1.9 %
tot. 257214 16.389 16 3853 26.9 %
Specimen 4 tot. 177286 12.694 14 3008 4.2 %
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that sometimes emerges after the instance segmentation step: neurons that are too close to each
other are sometimes identified as a single unit. All the 2.5D computations have been performed
on a standard Linux-based workstation equipped with the ALIQUIS software ecosystem [33],
using Google TensorFlow as the CNN backend [34].
The ground truth was annotated by two distinct operators on LAIRA, a web-based collaborative
application [35]. By following an Active Learning paradigm [36] the network was incrementally
trained against a number of positive and negative samples originating from the four specimens to
improve inter-specimen statistical representatives: the final training dataset is composed of 112
images of 512 × 512 px, corresponding to 450 × 450 µm, for a total of 7312 manually annotated
neurons (1180 from the first annotation without Active Learning). 14 independent images (1505
neurons) were used to validate the CNN and an additional 14 images (1208 neurons) to test it.
Model regularization is provided in the form of dropout layers, each with a dropout factor of 0.5.
The manually annotated ground truth used to train the neural network is also made available for
download on the EBRAINS platform [29] in Ximage format [37] (see Supplement 1 and Dataset
1 [38]).
2.6. Data analysis
The physical boundaries of the neuronal soma were stored in the form of triangular meshes in
Alembic [39] binary file format, which is suitable for rendering and for further analysis. These
files were then processed with Python scripts.
For volumetric evaluation, thresholds were applied to remove segmentation artifacts: volumes
lower than 400 µm3 and higher than 12000 µm3 were discarded. To visualize neuronal count,
density and mean volume distributions of the analyzed samples, we plotted histograms using 3D
moving bins of 100 × 100 × 100 µm as shown in Fig. 4. The centroid of the identified meshes
was used to assign each object to their corresponding histogram bin. Then, using the masks that
were manually drawn for each cortical layer (Fig. S11 in Supplement 1), we extracted cell counts
and densities as shown in Table 2.
3. Results
3.1. SWITCH/TDE clearing and labeling approach
Penetration of macromolecules and light deep inside the sample are critical processes that are
necessary to obtain homogeneous staining of the sample and to reach high transparency, which is
essential to perform 3D optical reconstruction with fluorescence imaging. In order to obtain a
reliable methodology to label and clear human brain samples from different regions, subjects,
and fixation conditions, we modified the SWITCH tissue transformation protocol [19] and we
combined it with the 2, 2′-thiodiethanol (TDE) clearing method [15] (Fig. 1(a)). Amongst the
various techniques, we decided to use the SWITCH methodology since it allows to control the
chemical interaction time and kinetics taking place inside the tissue. By modifying the solutions
used during the fixation and clearing, we achieved more uniform processing of tissues up to 1
mm. At first, we optimized the fixation condition during the SWITCH protocol lowering the
concentration of glutaraldehyde (from 1 % to 0.5 %) during the SWITCH ON step (data not
shown). Then, depending on tissue characteristics, we incubated the different samples in the
SWITCH clearing solution at 70◦C from 6 hours to one day. Finally, we used the aqueous agent
TDE to reduce the Refractive Index (RI) inhomogeneity between the tissue and the surrounding
medium, thus minimizing the scattering of light and guaranteeing the final transparency of the
sample (Fig. 1(b)). Differently from our previous paper [15], we used one-day serial incubations
at Room Temperature (RT) up to a concentration of 68 % TDE in Phosphate Buffered Saline
(PBS) to obtain homogeneous clearing of both grey and white matter. The final solution is
characterized by a refractive index of 1.46 equal to that of the UV silica glass used for imaging.
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The combination of the two techniques allows deep tissue imaging with Two-Photon Fluorescence
Microscopy (TPFM): small molecules as SYTOX Green can be imaged up to 1 mm in-depth,
while antibodies can homogeneously label 500 µm-thick slices, respectively (Figs. 1(c), d).
Finally, we demonstrated the compatibility of the SWITCH/TDE method with human brain
immunostaining using a variety of different antibodies (Table 1), which were able to stain
neuronal cells, GABAergic interneurons and interneurons subtypes, neuronal fibers, glial cells,
and microvasculature. Incubation time and temperature parameters optimizations are described
in the supplementary materials (Fig. S1 in Supplement 1). Representative images of the different
staining are shown in Fig. 1(e).
3.2. 3D reconstruction of cerebral cortex samples
The SWITCH/TDE protocol is able to clear different areas of the human brain cortex from
subjects of different ages (pediatric, adult, and elderly), obtained from biopsies collected during
epilepsy surgery interventions or autopsy stored up to 7 years in formalin (Fig. S1 in Supplement
1). To demonstrate the versatility of the method, four different human brain specimens, from
healthy and diseased patients, were analyzed. Two different portions of the left prefrontal cortex
from an adult (Male, 67 years old, sample 1) and an elderly subject (Female, 99 years old, no
Alzheimer’s disease but initial cognitive decline, no hypertension; sample 2); one dysplastic brain
sample from the left temporo-occipital cortex of a 29-year-old man operated to treat drug resistant
epilepsy due to focal cortical dysplasia Type IIa (FCDIIa), and one dysplastic brain sample from
the left temporo-parietal cortex of an eight-year-old boy operated to treat drug resistant epilepsy
due to hemimegalencephaly (HME), respectively samples 3 and 4. The samples were treated with
the SWITCH/TDE clearing method and immunolabeled with the Neuron-specific Nuclear protein
(NeuN) to detect neurons and DAPI for nuclear staining (sample area of ≈ 1× 1 cm2 and depth of
≈ 500 µm). Imaging was performed with a custom-made Two-Photon Fluorescence Microscope
designed to perform mesoscopic reconstruction with a resolution of (0.88 × 0.88 × 2) µm, see
Fig. 2 and Fig. S3 in Supplement 1. After the acquisition, adjacent stacks were aligned and
merged together by evaluating the cross-correlation of the overlapping areas using a custom-made
stitching software called ZetaStitcher [28].
3.3. Neuronal distribution analysis
The volumetric 3D reconstruction obtained with the TPFM consists of tens of GB of data. In
particular, the fused volumes of the four samples acquired in this work are sized 19, 50, 57 and
52 GB. Moreover, the image contrast variability in the different samples prevented the use of
traditional methods (Fig. S4 in Supplement 1). Therefore, to automatically obtain quantitative
information from the 3D reconstruction of the samples imaged with the TPFM, we used a 2D
Convolutional Neural Network for pixel-based classification expanding on the design employed
in a previous work [30].
The so-called 2.5D approach allowed us to perform both cell counting and cell volumetric
segmentation using different parameters. A detailed description of the method can be found
in the method section and in the supplementary material (Figs. S5, S6, in Supplement 1 and
Visualization 1). The statistical assessment of the 2.5D performance was determined by analyzing
four representative stacks of 100 × 100 × 100 µm, one for each specimen, and a representative
stack of 100 × 100 × 450 µm to determine the accuracy along with the full depth (Fig. S7 in
Supplement 1). The total number of neurons found by the 2.5D method is 442 over the 474
neurons annotated in the GT, and the volumetric evaluation of the neurons is characterized by
a precision and a recall rate respectively, equal to (91 ± 7) % and (96 ± 3) %. To verify the
stability of the 2.5D approach along the tissue depth, we plotted the z-profiles for cell counts,
mean volume, and volumetric density across different regions of the cortex along 10 different
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Fig. 2. (a) Pictures showing the four analyzed human brain specimens before and after
SWITCH/TDE clearing. A representative middle plane (z ≈ 200 µm) of the mesoscopic
reconstruction obtained with TPFM is shown next to each specimen. Scale bar = 1 mm.
Specimens 1 and 2: two different portions of the left prefrontal cortex from adult and elderly
subjects. Specimens 3 and 4: two surgically removed pieces from patients affected by Focal
Cortical Dysplasia Type 2a (FCDIIa) and by Hemimegalencephaly (HME), respectively. (b)
Magnified insets of specimen 1 (magenta) and 4 (cyan) showing the native resolution of the
acquisition. Tissues were stained with an anti-NeuN antibody (in red) and with DAPI (in
green). Scale bar = 100 µm
lines that were manually drawn orthogonally to the cortical layers in specimens 1, 2, and 3 (Figs.
S8-S11 in Supplement 1).
The four datasets acquired with the TPFM were processed with the 2.5D automatic segmentation
method, obtaining meshes for every single neuron in the whole volume (Visualization 2). Figure 3
shows a 3D rendering of the meshes for each processed specimen. The rendering highlights
the anatomical architecture of the six cortical layers. To characterize the structural organization
in the analyzed tissues, we calculated the cell density, the mean volume, and the volumetric
density distributions. The corresponding maps were obtained, for each specimen, with a 3D
moving average of 100 × 100 × 100 µm with a binning of 10 µm (Fig. 4(a), b, c). The images
show the presence of different peaks along with the cortical depth. In particular, volume profiles
show peaks in layers 3 and 5, while the neuronal density has peaks in layers 2 and 4. Figures
S8-S11 in Supplement 1 show 10 representative profiles for each specimen characterizing the
trend of the distributions in different areas of the cortex. Finally, we calculated the densities and
the percentage of neuronal counting and mean volume for the total volume of the grey matter
of the sample. To do that, a mask for the grey matter of each sample was manually drawn. To
quantify the neuronal distribution along with the six cortical layers, masks of each layer volume
were manually drawn for each sample (Fig. S12 in Supplement 1). The HME biopsy (sample
4) showed a disruption of the structural organization of the cortex, making layer classification
impossible. The results of counting and mean neuronal volumetric assessment are shown in
Table 2, numbers are provided for the overall volume and divided into the six cortical layers.
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Fig. 3. Panels a, f, g, h show the 3D rendering for specimens 1, 2, 3 and 4 respectively. The
magnified view of the highlighted squares in panel a from top to bottom are shown in panels
b, c, d, e, highlighting the neuronal size and density in the different cortical layers.
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Fig. 4. Representative distribution maps of the cell counting (a), mean volume (b),
volumetric density (c), and overlay of the three maps (d) of the middle plane of each
specimen.
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4. Discussion and conclusion
In this work, addressing some of the most critical challenges of human brain mapping (i.e., sample
preparation, mesoscopic reconstruction at high resolution, and big data analysis), we enabled a
3D characterization of the cytoarchitecture of the tissue at high resolution. In comparison to
animal brains, human neural tissues present high variability of post-mortem fixation conditions
and antigens alterations that prevent proper immunostaining recognition. In this work, we
combined the SWITCH tissue transformation method with the TDE clearing. The SWITCH
technique removes lipids from the sample while maintaining structural integrity, leading to an
increase of tissue permeability and a reduction of the tissue refractive index (RI). The TDE
clearing method homogenizes the RI of the sample with that of the mounting medium to reach
the final transparency. The optimized protocol can perform a rapid and efficient tissue clearing
and homogeneously stain the tissue with small molecules (up to 1 mm in-depth) as well as
antibodies (up to 500 µm). We provided a table of tested antibodies and molecules suitable
with the protocol for neuronal and non-neuronal cells as well as blood vessel staining. The
compatibility with different staining demonstrates the preservation of the tissue’s structure.
Indeed, the protocol, unlike others, does not employ aggressive denaturant agents which can
affect the tissue architecture and antigenicity of endogenous biomolecules. [9]. In addition,
the SWITCH treatment, using the GA to protect the tissue integrity and a high temperature
to remove the lipids, allows to speed up the delipidation process and complete it in 4-5 days
(considering also the fixation in GA), overcoming the limitation of using direct SDS treatment,
that in prolongated formalin-fixated samples needs a long delipidation step (up to several months)
[18,21]. On the other side, SWITCH/TDE protocol is still not optimized for paraffin-embedded
samples [40] limiting its applicability on prolonged formalin-fixed brain samples. In the future,
we plan to test the possibility of performing multi-round labelling of the tissue and carry out
multiple antibody co-staining to implement the characterization of the specimens as already
proposed by other authors [14,19,23].
To illustrate the versatility of the method, we used the SWITCH/TDE approach to prepare
volumetric samples (1010 µm3-sized volume) from different areas of the cerebral cortex from
adult control subjects and pediatric patients with malformations of cortical development. The
entire volumes, labeled with anti-NeuN antibody and DAPI, were acquired using a custom-made
Two-Photon Fluorescence Microscope (TPFM) capable of performing mesoscopic reconstruction
at sub-micron resolution. The optical sectioning and the high-resolution optical investigation
made possible by TPFM, in combination with the tissue clearing technique, allowed imaging of
the 3D organization of whole neurons lowering visual artifacts.
Volumetric imaging of samples generates a large amount of data (from tens of GB to tens
of TB) that needs to be processed in an automated fashion to extract reliable and quantitative
information. The software tools exploited in this study made it possible to analyze such big data.
As a first step, we stitched together the 3D tiles acquired using the TPFM microscope. Adjacent
tiles were aligned and merged by evaluating the cross-correlation of the overlapping areas using a
custom-made software called Zetastitcher. Once stitched, we performed an automatic cell analysis
using a 2.5D Machine Learning approach to perform neuronal mean volume assessment and cell
counting. The volumetric assessment gives the possibility to extract morphological information
that help to discriminate cell types using general staining as NeuN, reducing the labels necessary
for the analysis (a critical point in human tissue preparation). We evaluated the accuracy of the
2.5D approach in different specimens but also along the stack depth to demonstrate that our
analysis allows us to perform reliable quantitative evaluation of neuronal distributions in 3D
showing that labeling with our clearing protocol is sufficient to provide enough contrast for the
analysis.
Quantitative evaluations were performed on four different specimens (two different samples of
prefrontal cortex from an adult and an elderly subject, one dysplastic brain sample from the left
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temporo-occipital cortex of a patient with FCDIIa, and one dysplastic brain sample from the
left temporo-parietal cortex of a patient with HME) cleared with the SWITCH/TDE technique
and acquired with the TPFM. The presented approach proved to be robust and applicable to
the different specimens through the scanned surface and the depth. By mapping the neurons in
3D we characterized the cell density distribution and mean volume cells allowing us to assess
the morphological differences between the arrangement of the layers in the analyzed samples.
However, given the small number of samples we analyzed and the general purpose of this study,
we did not assess the possible differences between control and dysplastic brain tissues.
Despite the innovation proposed here, there are still several points that need to be considered to
obtain a faster, high-throughput, and informative automated characterization of tissue architecture.
A combination with a faster optical technique, such as light-sheet microscopy, could facilitate
scaling up the analysis. At the same time, further implementations of the automatic analysis
methods could reduce the errors associated with neuronal counting and volume estimation.
Nevertheless, we believe that our approach could be used in the future, not only to provide the
anatomical description of samples but also to reduce interpretation biases and to obtain a more
precise diagnostic neuropathological assessment. Indeed, morphological evaluation which still
relies on traditional methods, cannot provide enough information for unequivocal classification.
For example, MCD classification relies on an integrated diagnostic workflow which includes,
in addition to histological evaluation, clinical, neuroradiological, and molecular investigations
[9]. The 3D imaging approach we developed has the potential to introduce new classification
paradigms that could solve conflicting situations. Identifying what is the minimum number
of dysplastic neurons necessary to trigger seizures and how connections with the surrounding
normal environment act on seizures spreading, is mandatory to better define the pathophysiology
underlying FCD and related disorders. Traditional immunohistochemical methods based on the
analysis of slices with 10 − 40 µm of thickness do not allow an easy and univocal count of the
number of abnormal cells in a given specimen or reconstruct all connections originating from
and arriving at dysplastic cells. Although additional implementations are needed to selectively
stain dysplastic cells, the goal of accurate cell and connection counting may be achieved through
the analysis of large volumes of brain tissue, allowed by the protocol we describe. Indeed, the
increase in statistical accuracy and the sensitivity of the assessment provided by 3D evaluations
have already been demonstrated in tumors diagnosing and in stratifying patient prognosis [40].
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